OracleScan monitored market evidence

xyz:NVDA

critical condition with complete evidence coverage.

  • Oracle 152.9; mark 152.94
  • Observed open interest $411,644,516
  • Observed at 2026-11-19T08:50:30.351Z
  • All configured health components available

Open interactive retained evidence